ADVERTISEMENT

Apollo Hospitals' Strategic Demerger Sets Stage For Long-Term Value Creation; Motilal Oswal Maintains 'Buy'

Apollo Hospital has guided that the demerged entity NewCo is expected to achieve Rs 250 billion in revenue by FY27.

<div class="paragraphs"><p>Apollo Hospital has guided that the demerged entity (NewCo) is expected to achieve Rs 250 billion in revenue by FY27, with a targeted Ebitda margin of 7%, driven by the scale-up of digital health services and deeper pharmacy penetration. (Source: Company website)</p></div>
Apollo Hospital has guided that the demerged entity (NewCo) is expected to achieve Rs 250 billion in revenue by FY27, with a targeted Ebitda margin of 7%, driven by the scale-up of digital health services and deeper pharmacy penetration. (Source: Company website)
The demerger allows for a sharper strategic focus, with Apollo Hospitals Enterprise Ltd. concentrating on core healthcare services, while NewCo drives growth in digital health and pharmacy distribution under dedicated leadership.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit